<DOC>
	<DOC>NCT00219869</DOC>
	<brief_summary>Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).</brief_summary>
	<brief_title>Galantamine in the Treatment of Post-Traumatic Headache</brief_title>
	<detailed_description>Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache clinics, posing a severe burden and affecting the quality of life of sufferers.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<mesh_term>Post-Traumatic Headache</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Head Injuries, Closed</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Age range 1875 CPTH according to ICHD2 Fertile woman using adequate birth control Willing and able to give informed consent Willing and able to complete the entire course of the study to comply with study instructions Stable does of preventive medication Subject is pregnant or lactating Significant medical or psychiatric disease Previous failure to 4 or more adequate trials of preventive medication Patient on nonstable dose of medication used to prevent CPTH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Post</keyword>
	<keyword>Traumatic</keyword>
	<keyword>Headache</keyword>
	<keyword>Cognitive</keyword>
</DOC>